Medical Care
Global Veterinary Regenerative Medicine Market Research Report 2025
- May 05, 25
- ID: 228469
- Pages: 89
- Figures: 86
- Views: 10
The global market for Veterinary Regenerative Medicine was valued at US$ 335 million in the year 2024 and is projected to reach a revised size of US$ 760 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
This report aims to provide a comprehensive presentation of the global market for Veterinary Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Regenerative Medicine.
The Veterinary Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis
Segment by Type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Regenerative Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
This report aims to provide a comprehensive presentation of the global market for Veterinary Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Regenerative Medicine.
The Veterinary Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis
Segment by Type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Regenerative Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Platelet-Rich Plasma (PRP)
1.2.3 Stem Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Regenerative Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Veterinary Hospitals/Clinics
1.3.3 Veterinary Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Regenerative Medicine Market Perspective (2020-2031)
2.2 Global Veterinary Regenerative Medicine Growth Trends by Region
2.2.1 Global Veterinary Regenerative Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary Regenerative Medicine Historic Market Size by Region (2020-2025)
2.2.3 Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031)
2.3 Veterinary Regenerative Medicine Market Dynamics
2.3.1 Veterinary Regenerative Medicine Industry Trends
2.3.2 Veterinary Regenerative Medicine Market Drivers
2.3.3 Veterinary Regenerative Medicine Market Challenges
2.3.4 Veterinary Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Regenerative Medicine Players by Revenue
3.1.1 Global Top Veterinary Regenerative Medicine Players by Revenue (2020-2025)
3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Veterinary Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary Regenerative Medicine Revenue
3.4 Global Veterinary Regenerative Medicine Market Concentration Ratio
3.4.1 Global Veterinary Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Regenerative Medicine Revenue in 2024
3.5 Global Key Players of Veterinary Regenerative Medicine Head office and Area Served
3.6 Global Key Players of Veterinary Regenerative Medicine, Product and Application
3.7 Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Regenerative Medicine Breakdown Data by Type
4.1 Global Veterinary Regenerative Medicine Historic Market Size by Type (2020-2025)
4.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031)
5 Veterinary Regenerative Medicine Breakdown Data by Application
5.1 Global Veterinary Regenerative Medicine Historic Market Size by Application (2020-2025)
5.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary Regenerative Medicine Market Size (2020-2031)
6.2 North America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary Regenerative Medicine Market Size by Country (2020-2025)
6.4 North America Veterinary Regenerative Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Regenerative Medicine Market Size (2020-2031)
7.2 Europe Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025)
7.4 Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Regenerative Medicine Market Size (2020-2031)
8.2 Asia-Pacific Veterinary Regenerative Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Regenerative Medicine Market Size (2020-2031)
9.2 Latin America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025)
9.4 Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Regenerative Medicine Market Size (2020-2031)
10.2 Middle East & Africa Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACell Inc. (Integra LifeSciences)
11.1.1 ACell Inc. (Integra LifeSciences) Company Details
11.1.2 ACell Inc. (Integra LifeSciences) Business Overview
11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Introduction
11.1.4 ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.1.5 ACell Inc. (Integra LifeSciences) Recent Development
11.2 Animal Cell Therapies, Inc.
11.2.1 Animal Cell Therapies, Inc. Company Details
11.2.2 Animal Cell Therapies, Inc. Business Overview
11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Introduction
11.2.4 Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.2.5 Animal Cell Therapies, Inc. Recent Development
11.3 Ardent
11.3.1 Ardent Company Details
11.3.2 Ardent Business Overview
11.3.3 Ardent Veterinary Regenerative Medicine Introduction
11.3.4 Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.3.5 Ardent Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Details
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Cell Therapy Sciences
11.5.1 Cell Therapy Sciences Company Details
11.5.2 Cell Therapy Sciences Business Overview
11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Introduction
11.5.4 Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.5.5 Cell Therapy Sciences Recent Development
11.6 Dechra
11.6.1 Dechra Company Details
11.6.2 Dechra Business Overview
11.6.3 Dechra Veterinary Regenerative Medicine Introduction
11.6.4 Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.6.5 Dechra Recent Development
11.7 Enso Discoveries
11.7.1 Enso Discoveries Company Details
11.7.2 Enso Discoveries Business Overview
11.7.3 Enso Discoveries Veterinary Regenerative Medicine Introduction
11.7.4 Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.7.5 Enso Discoveries Recent Development
11.8 South Paws Veterinary Surgical Specialists
11.8.1 South Paws Veterinary Surgical Specialists Company Details
11.8.2 South Paws Veterinary Surgical Specialists Business Overview
11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Introduction
11.8.4 South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.8.5 South Paws Veterinary Surgical Specialists Recent Development
11.9 Veterinary Specialty Center
11.9.1 Veterinary Specialty Center Company Details
11.9.2 Veterinary Specialty Center Business Overview
11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Introduction
11.9.4 Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.9.5 Veterinary Specialty Center Recent Development
11.10 Vetbiologics
11.10.1 Vetbiologics Company Details
11.10.2 Vetbiologics Business Overview
11.10.3 Vetbiologics Veterinary Regenerative Medicine Introduction
11.10.4 Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.10.5 Vetbiologics Recent Development
11.11 Vetherapy
11.11.1 Vetherapy Company Details
11.11.2 Vetherapy Business Overview
11.11.3 Vetherapy Veterinary Regenerative Medicine Introduction
11.11.4 Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.11.5 Vetherapy Recent Development
11.12 VetStem, Inc.
11.12.1 VetStem, Inc. Company Details
11.12.2 VetStem, Inc. Business Overview
11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Introduction
11.12.4 VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.12.5 VetStem, Inc. Recent Development
11.13 Zoetis
11.13.1 Zoetis Company Details
11.13.2 Zoetis Business Overview
11.13.3 Zoetis Veterinary Regenerative Medicine Introduction
11.13.4 Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.13.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Platelet-Rich Plasma (PRP)
1.2.3 Stem Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Regenerative Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Veterinary Hospitals/Clinics
1.3.3 Veterinary Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Regenerative Medicine Market Perspective (2020-2031)
2.2 Global Veterinary Regenerative Medicine Growth Trends by Region
2.2.1 Global Veterinary Regenerative Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary Regenerative Medicine Historic Market Size by Region (2020-2025)
2.2.3 Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031)
2.3 Veterinary Regenerative Medicine Market Dynamics
2.3.1 Veterinary Regenerative Medicine Industry Trends
2.3.2 Veterinary Regenerative Medicine Market Drivers
2.3.3 Veterinary Regenerative Medicine Market Challenges
2.3.4 Veterinary Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Regenerative Medicine Players by Revenue
3.1.1 Global Top Veterinary Regenerative Medicine Players by Revenue (2020-2025)
3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Veterinary Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary Regenerative Medicine Revenue
3.4 Global Veterinary Regenerative Medicine Market Concentration Ratio
3.4.1 Global Veterinary Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Regenerative Medicine Revenue in 2024
3.5 Global Key Players of Veterinary Regenerative Medicine Head office and Area Served
3.6 Global Key Players of Veterinary Regenerative Medicine, Product and Application
3.7 Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Regenerative Medicine Breakdown Data by Type
4.1 Global Veterinary Regenerative Medicine Historic Market Size by Type (2020-2025)
4.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031)
5 Veterinary Regenerative Medicine Breakdown Data by Application
5.1 Global Veterinary Regenerative Medicine Historic Market Size by Application (2020-2025)
5.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary Regenerative Medicine Market Size (2020-2031)
6.2 North America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary Regenerative Medicine Market Size by Country (2020-2025)
6.4 North America Veterinary Regenerative Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Regenerative Medicine Market Size (2020-2031)
7.2 Europe Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025)
7.4 Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Regenerative Medicine Market Size (2020-2031)
8.2 Asia-Pacific Veterinary Regenerative Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Regenerative Medicine Market Size (2020-2031)
9.2 Latin America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025)
9.4 Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Regenerative Medicine Market Size (2020-2031)
10.2 Middle East & Africa Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACell Inc. (Integra LifeSciences)
11.1.1 ACell Inc. (Integra LifeSciences) Company Details
11.1.2 ACell Inc. (Integra LifeSciences) Business Overview
11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Introduction
11.1.4 ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.1.5 ACell Inc. (Integra LifeSciences) Recent Development
11.2 Animal Cell Therapies, Inc.
11.2.1 Animal Cell Therapies, Inc. Company Details
11.2.2 Animal Cell Therapies, Inc. Business Overview
11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Introduction
11.2.4 Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.2.5 Animal Cell Therapies, Inc. Recent Development
11.3 Ardent
11.3.1 Ardent Company Details
11.3.2 Ardent Business Overview
11.3.3 Ardent Veterinary Regenerative Medicine Introduction
11.3.4 Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.3.5 Ardent Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Details
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Cell Therapy Sciences
11.5.1 Cell Therapy Sciences Company Details
11.5.2 Cell Therapy Sciences Business Overview
11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Introduction
11.5.4 Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.5.5 Cell Therapy Sciences Recent Development
11.6 Dechra
11.6.1 Dechra Company Details
11.6.2 Dechra Business Overview
11.6.3 Dechra Veterinary Regenerative Medicine Introduction
11.6.4 Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.6.5 Dechra Recent Development
11.7 Enso Discoveries
11.7.1 Enso Discoveries Company Details
11.7.2 Enso Discoveries Business Overview
11.7.3 Enso Discoveries Veterinary Regenerative Medicine Introduction
11.7.4 Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.7.5 Enso Discoveries Recent Development
11.8 South Paws Veterinary Surgical Specialists
11.8.1 South Paws Veterinary Surgical Specialists Company Details
11.8.2 South Paws Veterinary Surgical Specialists Business Overview
11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Introduction
11.8.4 South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.8.5 South Paws Veterinary Surgical Specialists Recent Development
11.9 Veterinary Specialty Center
11.9.1 Veterinary Specialty Center Company Details
11.9.2 Veterinary Specialty Center Business Overview
11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Introduction
11.9.4 Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.9.5 Veterinary Specialty Center Recent Development
11.10 Vetbiologics
11.10.1 Vetbiologics Company Details
11.10.2 Vetbiologics Business Overview
11.10.3 Vetbiologics Veterinary Regenerative Medicine Introduction
11.10.4 Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.10.5 Vetbiologics Recent Development
11.11 Vetherapy
11.11.1 Vetherapy Company Details
11.11.2 Vetherapy Business Overview
11.11.3 Vetherapy Veterinary Regenerative Medicine Introduction
11.11.4 Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.11.5 Vetherapy Recent Development
11.12 VetStem, Inc.
11.12.1 VetStem, Inc. Company Details
11.12.2 VetStem, Inc. Business Overview
11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Introduction
11.12.4 VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.12.5 VetStem, Inc. Recent Development
11.13 Zoetis
11.13.1 Zoetis Company Details
11.13.2 Zoetis Business Overview
11.13.3 Zoetis Veterinary Regenerative Medicine Introduction
11.13.4 Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025)
11.13.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Veterinary Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Platelet-Rich Plasma (PRP)
Table 3. Key Players of Stem Cell Therapy
Table 4. Key Players of Others
Table 5. Global Veterinary Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Veterinary Regenerative Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Veterinary Regenerative Medicine Market Share by Region (2020-2025)
Table 9. Global Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Veterinary Regenerative Medicine Market Share by Region (2026-2031)
Table 11. Veterinary Regenerative Medicine Market Trends
Table 12. Veterinary Regenerative Medicine Market Drivers
Table 13. Veterinary Regenerative Medicine Market Challenges
Table 14. Veterinary Regenerative Medicine Market Restraints
Table 15. Global Veterinary Regenerative Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Veterinary Regenerative Medicine Market Share by Players (2020-2025)
Table 17. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)
Table 18. Ranking of Global Top Veterinary Regenerative Medicine Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Veterinary Regenerative Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Veterinary Regenerative Medicine, Headquarters and Area Served
Table 21. Global Key Players of Veterinary Regenerative Medicine, Product and Application
Table 22. Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Veterinary Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2020-2025)
Table 26. Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2026-2031)
Table 28. Global Veterinary Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2020-2025)
Table 30. Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2026-2031)
Table 32. North America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Veterinary Regenerative Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 47. ACell Inc. (Integra LifeSciences) Company Details
Table 48. ACell Inc. (Integra LifeSciences) Business Overview
Table 49. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product
Table 50. ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 51. ACell Inc. (Integra LifeSciences) Recent Development
Table 52. Animal Cell Therapies, Inc. Company Details
Table 53. Animal Cell Therapies, Inc. Business Overview
Table 54. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product
Table 55. Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 56. Animal Cell Therapies, Inc. Recent Development
Table 57. Ardent Company Details
Table 58. Ardent Business Overview
Table 59. Ardent Veterinary Regenerative Medicine Product
Table 60. Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 61. Ardent Recent Development
Table 62. Boehringer Ingelheim International GmbH Company Details
Table 63. Boehringer Ingelheim International GmbH Business Overview
Table 64. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product
Table 65. Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 66. Boehringer Ingelheim International GmbH Recent Development
Table 67. Cell Therapy Sciences Company Details
Table 68. Cell Therapy Sciences Business Overview
Table 69. Cell Therapy Sciences Veterinary Regenerative Medicine Product
Table 70. Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 71. Cell Therapy Sciences Recent Development
Table 72. Dechra Company Details
Table 73. Dechra Business Overview
Table 74. Dechra Veterinary Regenerative Medicine Product
Table 75. Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 76. Dechra Recent Development
Table 77. Enso Discoveries Company Details
Table 78. Enso Discoveries Business Overview
Table 79. Enso Discoveries Veterinary Regenerative Medicine Product
Table 80. Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 81. Enso Discoveries Recent Development
Table 82. South Paws Veterinary Surgical Specialists Company Details
Table 83. South Paws Veterinary Surgical Specialists Business Overview
Table 84. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product
Table 85. South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 86. South Paws Veterinary Surgical Specialists Recent Development
Table 87. Veterinary Specialty Center Company Details
Table 88. Veterinary Specialty Center Business Overview
Table 89. Veterinary Specialty Center Veterinary Regenerative Medicine Product
Table 90. Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 91. Veterinary Specialty Center Recent Development
Table 92. Vetbiologics Company Details
Table 93. Vetbiologics Business Overview
Table 94. Vetbiologics Veterinary Regenerative Medicine Product
Table 95. Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 96. Vetbiologics Recent Development
Table 97. Vetherapy Company Details
Table 98. Vetherapy Business Overview
Table 99. Vetherapy Veterinary Regenerative Medicine Product
Table 100. Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 101. Vetherapy Recent Development
Table 102. VetStem, Inc. Company Details
Table 103. VetStem, Inc. Business Overview
Table 104. VetStem, Inc. Veterinary Regenerative Medicine Product
Table 105. VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 106. VetStem, Inc. Recent Development
Table 107. Zoetis Company Details
Table 108. Zoetis Business Overview
Table 109. Zoetis Veterinary Regenerative Medicine Product
Table 110. Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 111. Zoetis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Veterinary Regenerative Medicine Picture
Figure 2. Global Veterinary Regenerative Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary Regenerative Medicine Market Share by Type: 2024 VS 2031
Figure 4. Platelet-Rich Plasma (PRP) Features
Figure 5. Stem Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Veterinary Regenerative Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Veterinary Regenerative Medicine Market Share by Application: 2024 VS 2031
Figure 9. Veterinary Hospitals/Clinics Case Studies
Figure 10. Veterinary Research Institutes Case Studies
Figure 11. Veterinary Regenerative Medicine Report Years Considered
Figure 12. Global Veterinary Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Veterinary Regenerative Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Veterinary Regenerative Medicine Market Share by Region: 2024 VS 2031
Figure 15. Global Veterinary Regenerative Medicine Market Share by Players in 2024
Figure 16. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Regenerative Medicine Revenue in 2024
Figure 18. North America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 20. United States Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 24. Germany Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Veterinary Regenerative Medicine Market Share by Region (2020-2031)
Figure 32. China Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 40. Mexico Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 44. Turkey Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ACell Inc. (Integra LifeSciences) Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 48. Animal Cell Therapies, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 49. Ardent Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 50. Boehringer Ingelheim International GmbH Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 51. Cell Therapy Sciences Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 52. Dechra Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 53. Enso Discoveries Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 54. South Paws Veterinary Surgical Specialists Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 55. Veterinary Specialty Center Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 56. Vetbiologics Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 57. Vetherapy Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 58. VetStem, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 59. Zoetis Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Veterinary Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Platelet-Rich Plasma (PRP)
Table 3. Key Players of Stem Cell Therapy
Table 4. Key Players of Others
Table 5. Global Veterinary Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Veterinary Regenerative Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Veterinary Regenerative Medicine Market Share by Region (2020-2025)
Table 9. Global Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Veterinary Regenerative Medicine Market Share by Region (2026-2031)
Table 11. Veterinary Regenerative Medicine Market Trends
Table 12. Veterinary Regenerative Medicine Market Drivers
Table 13. Veterinary Regenerative Medicine Market Challenges
Table 14. Veterinary Regenerative Medicine Market Restraints
Table 15. Global Veterinary Regenerative Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Veterinary Regenerative Medicine Market Share by Players (2020-2025)
Table 17. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)
Table 18. Ranking of Global Top Veterinary Regenerative Medicine Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Veterinary Regenerative Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Veterinary Regenerative Medicine, Headquarters and Area Served
Table 21. Global Key Players of Veterinary Regenerative Medicine, Product and Application
Table 22. Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Veterinary Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2020-2025)
Table 26. Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2026-2031)
Table 28. Global Veterinary Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2020-2025)
Table 30. Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2026-2031)
Table 32. North America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Veterinary Regenerative Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 47. ACell Inc. (Integra LifeSciences) Company Details
Table 48. ACell Inc. (Integra LifeSciences) Business Overview
Table 49. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product
Table 50. ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 51. ACell Inc. (Integra LifeSciences) Recent Development
Table 52. Animal Cell Therapies, Inc. Company Details
Table 53. Animal Cell Therapies, Inc. Business Overview
Table 54. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product
Table 55. Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 56. Animal Cell Therapies, Inc. Recent Development
Table 57. Ardent Company Details
Table 58. Ardent Business Overview
Table 59. Ardent Veterinary Regenerative Medicine Product
Table 60. Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 61. Ardent Recent Development
Table 62. Boehringer Ingelheim International GmbH Company Details
Table 63. Boehringer Ingelheim International GmbH Business Overview
Table 64. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product
Table 65. Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 66. Boehringer Ingelheim International GmbH Recent Development
Table 67. Cell Therapy Sciences Company Details
Table 68. Cell Therapy Sciences Business Overview
Table 69. Cell Therapy Sciences Veterinary Regenerative Medicine Product
Table 70. Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 71. Cell Therapy Sciences Recent Development
Table 72. Dechra Company Details
Table 73. Dechra Business Overview
Table 74. Dechra Veterinary Regenerative Medicine Product
Table 75. Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 76. Dechra Recent Development
Table 77. Enso Discoveries Company Details
Table 78. Enso Discoveries Business Overview
Table 79. Enso Discoveries Veterinary Regenerative Medicine Product
Table 80. Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 81. Enso Discoveries Recent Development
Table 82. South Paws Veterinary Surgical Specialists Company Details
Table 83. South Paws Veterinary Surgical Specialists Business Overview
Table 84. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product
Table 85. South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 86. South Paws Veterinary Surgical Specialists Recent Development
Table 87. Veterinary Specialty Center Company Details
Table 88. Veterinary Specialty Center Business Overview
Table 89. Veterinary Specialty Center Veterinary Regenerative Medicine Product
Table 90. Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 91. Veterinary Specialty Center Recent Development
Table 92. Vetbiologics Company Details
Table 93. Vetbiologics Business Overview
Table 94. Vetbiologics Veterinary Regenerative Medicine Product
Table 95. Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 96. Vetbiologics Recent Development
Table 97. Vetherapy Company Details
Table 98. Vetherapy Business Overview
Table 99. Vetherapy Veterinary Regenerative Medicine Product
Table 100. Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 101. Vetherapy Recent Development
Table 102. VetStem, Inc. Company Details
Table 103. VetStem, Inc. Business Overview
Table 104. VetStem, Inc. Veterinary Regenerative Medicine Product
Table 105. VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 106. VetStem, Inc. Recent Development
Table 107. Zoetis Company Details
Table 108. Zoetis Business Overview
Table 109. Zoetis Veterinary Regenerative Medicine Product
Table 110. Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 111. Zoetis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Veterinary Regenerative Medicine Picture
Figure 2. Global Veterinary Regenerative Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary Regenerative Medicine Market Share by Type: 2024 VS 2031
Figure 4. Platelet-Rich Plasma (PRP) Features
Figure 5. Stem Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Veterinary Regenerative Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Veterinary Regenerative Medicine Market Share by Application: 2024 VS 2031
Figure 9. Veterinary Hospitals/Clinics Case Studies
Figure 10. Veterinary Research Institutes Case Studies
Figure 11. Veterinary Regenerative Medicine Report Years Considered
Figure 12. Global Veterinary Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Veterinary Regenerative Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Veterinary Regenerative Medicine Market Share by Region: 2024 VS 2031
Figure 15. Global Veterinary Regenerative Medicine Market Share by Players in 2024
Figure 16. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Regenerative Medicine Revenue in 2024
Figure 18. North America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 20. United States Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 24. Germany Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Veterinary Regenerative Medicine Market Share by Region (2020-2031)
Figure 32. China Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 40. Mexico Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Veterinary Regenerative Medicine Market Share by Country (2020-2031)
Figure 44. Turkey Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ACell Inc. (Integra LifeSciences) Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 48. Animal Cell Therapies, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 49. Ardent Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 50. Boehringer Ingelheim International GmbH Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 51. Cell Therapy Sciences Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 52. Dechra Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 53. Enso Discoveries Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 54. South Paws Veterinary Surgical Specialists Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 55. Veterinary Specialty Center Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 56. Vetbiologics Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 57. Vetherapy Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 58. VetStem, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 59. Zoetis Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232